A meta-analysis suggests adverse events are often falsely attributed to BP-lowering drugs, leaving patients undertreated.

If you’ve ever sat in the emergency room with a broken bone or a severe back spasm, you might have noticed the nurse frowning ...

Switching off an enzyme that plays an important role in sugar metabolism, glycolysis, would normally be expected to cause serious problems for cells. Surprisingly, the opposite is also true: Cells can ...

Les Masterson is a deputy editor and insurance analyst at Forbes Advisor. He has been a journalist, reporter, editor and content creator for more than 25 years. He has covered insurance for a decade, ...

Positive results from the EMERALD-3 Phase III trial showed AstraZeneca's Imfinzi (durvalumab) in combination with Imjudo (tremelimumab), lenvatinib and transarterial chemoembolisation (TACE), ...